Mette Julsgaard
@JulsgaardMette
Physician and scientist @HepGas @AUHdk studying #IBD, with special focus on #fertility, #preconception, #pregnancy & #breastfeeding in IBD clinical research.
A tremendous honour receiving the #UEG #Rising_Star_award & giving a talk on #IBD & #pregnancy/lactation @UegWeek . Thank you @my_ueg ⭐️ Stay tuned for our #Global_Consensus on management of IBD in 🤰🏻@PIANOIBD @HepGas @AarhusUni @HealthAarhusUni @AUHdk
What are the risk factors for unplanned 🤰in women with IBD? 🧐 Data from PIANO 🎹 showed ⬆️ risk in women who: ➡️ Face 💰and educational barriers ⛔️ ➡️ Do not have a domestic partner ➡️ Belong to minority groups @EJBrenner_MD @UmaMahadevanIBD @MLongMD doi.org/10.1093/ibd/iz…
🚨Nationwide 🇩🇰study challenges the belief that laparoscopic #IPAA is safer for fertility than open #IPAA in women with #UC - no difference in birth rates or other fertility meassures. Important when counselling women with UC. @AUHdk @HepGas @OUHhospital pubmed.ncbi.nlm.nih.gov/40643458/
Highly relevat Congratulations Mette @JulsgaardMette
🤱#Upadacitinib detectable in breast milk(n=40) Relative Infant Dose 2.7% (IQR 0.8-10.6) RID ~ #tofacitinib but ⬆️ than other #IBD drugs. ⚠️with high GI bioavailability & unknown 👶🏼immune effects, avoid breastfeeding. Great collaboration 🇧🇪🇨🇿🇩🇪🇺🇸🇩🇰@AGA_CGH pubmed.ncbi.nlm.nih.gov/40571170/
Excellent paper, great information for clinical decisions 👏👏👏👇👇👇👇
🤱#Upadacitinib detectable in breast milk(n=40) Relative Infant Dose 2.7% (IQR 0.8-10.6) RID ~ #tofacitinib but ⬆️ than other #IBD drugs. ⚠️with high GI bioavailability & unknown 👶🏼immune effects, avoid breastfeeding. Great collaboration 🇧🇪🇨🇿🇩🇪🇺🇸🇩🇰@AGA_CGH pubmed.ncbi.nlm.nih.gov/40571170/
Congratulations for this excellent work my friend! You are a star ⭐️
Time for in-depth discussion, meaningful networking, and inspiring sessions on career development. This is what makes the Women in IBD EU Focus Meeting so unique. Join our co-chairs @JoanaTo62523004 and @MLongMD at our upcoming meeting in Spain on November 21–22, 2025. ✨ From…
Long term outcomes of biologic exposure in utero: @AKohli_MD presenting @PIANOIBD data showing no evidence of harm out to at least 4 years. @UCSFHospitals @DDWMeeting
FcRn protects IgG and albumin from catabolism, transports IgG across the placenta, and regulates IgG function. Blocking or augmenting FcRn can decrease autoimmune antibodies and enhance drug delivery. Learn more in the Review Article “Neonatal Fc Receptor — Biology and…
Important findings regarding IUS in 🤰🏻IBD patients. Well done @RalleyP @DrEmmaFlanagan @SallyBell & team 🇦🇺🇺🇸
Collaborating with our 🇦🇺 colleagues ✈️🌏 to understand the impact of disease monitoring in pregnant IBD pts. Bottom line ✅ sub-clinical disease activity on IUS into the 2nd trimester is associated with adverse outcomes and if you 👀🔦 it, you should alter your Tx strategy.
🌎patient recommendations in relation to #pregnancy & #IBD now available in 5 languages! This and the upcoming consensus will transform the care of 🤰🏼& their 👶🏼 ! An honour taking part in this novel project. Thx @UmaMahadevanIBD @MLongMD @HelmsleyTrust @PIANOIBD @HepGas @AUHdk
Thank you to all the physicians, scientists and patients who helped make this happen. Full manuscript in review. @MLongMD @JulsgaardMette @maria_chs @Siew_C_Ng @ibddocmaria and many more here : pianostudy.org/conference.php
#CGH4ALL Is continuation of UST safe in pregnancy? This new 📃evaluated pregnancy outcomes, developmental milestones, UST clearance and infections in UST-exposed infants. Check out the NEXUS study from 🇩🇰&🇳🇱 🔗doi.org/10.1016/j.cgh.… Summary by @NAggarwalMD…
Important clinical finding from the @PIANOIBD registry! Use biologics as maintenance treatment for #IBD in pregnancy and in general! Safer and Superior to immune modulators.
Delayed would healing after episotomy with immune modulator but not biologics among women with IBD. @PIANOIBD @SaraLewinMD @MLongMD @AmJGastro pubmed.ncbi.nlm.nih.gov/39779464/
Management of Hepatitis B in pregnancy! @norahterrault @GuildConference
Pregnant women with IBD should start low dose aspirin between weeks 12-16 gestation. This data supports no increase in flares. Take with food! @PIANOIBD @MLongMD
Great work from @zmemel @PIANOIBD. The Effect of Low-dose Aspirin on Disease Activity in... : Official journal of the American College of Gastroenterology | ACG journals.lww.com/ajg/abstract/9…
#GUTAbstract from @BonfilsLinea et al on the paper "Impact of prenatal and postnatal maternal IBD status on offspring’s risk of IBD: a population-based cohort study" via bit.ly/4gXfYWX Paper via: bit.ly/3yxTzPd @manasiagrawalmd @JulsgaardMette @PREDICTIBD…
Highly recommendable - #Women_in_IBD conference: state of the art lectures in IBD & excellent networking/social interaction.
🎉 Thrilled to share impressions from this year’s Women in IBD meeting in London! Hear from our incredible faculty about what makes this event so special. 🌟 📍 Save the date: WiIBD 2025 will be in Madrid, 21-22 November, 2025! Stay tuned—agenda & details are coming soon. 📩…
Women in IBD 2024 🇬🇧 Thank you @MLongMD and @JoanaTo62523004 for an ambitious meeting that clearly demonstrates the excellence of female speakers in the field. We look forward to achieving a 50:50 gender balance in future IBD meetings – both academic and industry-sponsored!